6hon MSN
Gain insight on Centessa Pharmaceuticals, Novo Nordisk and more in the latest Market Talks covering the Health Care sector.
With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discounted prices. Second, Novo is ...
12h
Zacks Investment Research on MSNNovo Nordisk Down 15% in March: Is This a Buying Opportunity?Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also ...
The German software company's share price gained 40% in the past year, while Danish drugmaker Novo Nordisk has gradually lost ...
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
As part of the agreement with a United Lab unit announced on Monday, Novo will make an upfront payment of $200 million and up to $1.8 billion upon the completion of certain development and sales ...
German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market ...
Berenberg Bank analyst Kerry Holford maintained a Hold rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
German software developer SAP SE unseated Danish weight-loss drug maker Novo Nordisk A/S as Europe’s most-valuable public ...
Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results